Perspective Therapeutics, Inc. (CATX)
3.85
+0.08
(+2.12%)
USD |
NYAM |
May 21, 11:56
Perspective Therapeutics EPS Diluted (Quarterly) : -0.2528 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -1.045 |
| AVITA Medical, Inc. | -0.3474 |
| Twist Bioscience Corp. | -0.7134 |
| Elutia, Inc. | -0.1836 |
| TriSalus Life Sciences, Inc. | 0.0294 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.19M |
| Revenue (Quarterly) | 0.076M |
| Total Expenses (Quarterly) | 26.26M |
| Enterprise Value | 163.26M |
| Gross Profit Margin (Quarterly) | -1.38K% |
| Profit Margin (Quarterly) | -34.46K% |
| Earnings Yield | -36.26% |
| Normalized Earnings Yield | -33.82 |